DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Siramesine
Siramesine
Modifications to the Harmonized Tariff Schedule of the United States To
Drug Sequestration in Lysosomes As One of the Mechanisms of Chemoresistance of Cancer Cells and the Possibilities of Its Inhibition
The Lysosomotropic Activity of Hydrophobic Weak Base Drugs Is Mediated Via Their Intercalation Into the Lysosomal Membrane
I Regulations
Customs Tariff - Schedule
Sigma1 Pharmacology in the Context of Cancer
Imaging Small Molecule-Induced Endosomal Escape of Sirna
Pharmaceutical Composition and Dosage Forms for Administration of Hydrophobic Drugs
Stembook 2018.Pdf
Potential Antidepressant Effect of Amantadine: a Review of Preclinical Studies and Clinical Trials Inara F
Effective Tumor Cell Death by S-2 Receptor Ligand Siramesine Involves Lysosomal Leakage and Oxidative Stress
Customs Tariff - Schedule
(12) Patent Application Publication (10) Pub. No.: US 2010/0184806 A1 Barlow Et Al
The Antidepressant Sertraline Targets Intracellular Vesiculogenic
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Ligands with Antiproliferative and Anticancer Activity
In Vitro Confirmation of Siramesine As a Novel
Customs Tariff - Schedule
Top View
Sigma Receptor
Mdl-Forp0018549.Tif
Siramesine and Lapatinib Induce Synergic Cell Death Via a Ferroptotic Mechanism in Lung Adenocarcinoma and Glioblastoma Cells
Customs Tariff - Schedule Xxi - 1
Use of Low Dose Pipamperone and a Second Active Compound in the Treatment of Neurodegenerative Diseases
Potential Antidepressant Activity of Sigma Ligands
Evaluation of Novel Sigma Receptor Antagonists Against METH- Induced Neurotoxicity: in Vivo and in Vitro Studies
The Antidepressant Sertraline Targets Intracellular Vesiculogenic Membranes in Yeast
African Americans and Cough Syrup with Codeine Abuse
Identification of the PGRMC1 Protein Complex As the Putative Sigma-2 Receptor Binding Site
Sigma-2 Ligands Induce Tumour Cell Death by Multiple Signalling Pathways
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Study of the Relationship Between Sigma Receptor Expression Levels
WO 2007/053596 Al
Annual Report 1999 1999 Was Both an Eventful and a Successful Year for H
Table [1]: Definition of Reported Outcomes Study Outcome
Binding of Siramesine to Phosphatidicacid Khandelia, Himanshu
2 Receptor and Its Role in Cancer with Focus on a Multitarget Directed Ligand (MTDL) Approach
The Role of Progesterone Receptor Membrane Component 1 in Receptor Trafficking and Disease
Expression of Sigma Receptors in Human Cancer Cell Lines and Effects of Novel Sigma-2 Ligands on Their
(12) Patent Application Publication (10) Pub. No.: US 2016/0053029 A1 JHA Et Al
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Amantadine: Reappraisal of the Timeless Diamond—Target Updates and Novel Therapeutic Potentials
University of Groningen Sigma-1 Receptor Imaging in the Brain
Horizon Scanning COVID-19 Supplement Status Report, Volume
The Synergistic Effect of Selective Sigma Receptor
The Cholinergic System, Sigma-1 Receptors and Cognition
Neuronal Signature of an Antipsychotic Response
Acute Effects of the Sigma-2 Receptor Agonist Siramesine on Lysosomal and Extra-Lysosomal Proteolytic Systems in Lens Epithelial Cells
Potential Applications for Sigma Receptor Ligands in Cancer Diagnosis and Therapy☆
A Screening Campaign in Sea Urchin Egg Homogenate As a Platform for Discovering Modulators of NAADP-Dependent Ca2+ Signaling in Human Cells T
Role of Sigma Receptors in Methamphetamine-Induced Neurotoxicity
Pharmacokinetic Evaluation of a Novel Compound, Sn79, a Putative Sigma-2 Receptor Antagonist, by Intravenous and Oral Administration in Rats